Skip to main content
Premium Trial:

Request an Annual Quote

Shawn Clairmont

Codexis has appointed Shawn Clairmont senior director of molecular diagnostics. She will be responsible for commercial activities related to the firm's molecular diagnostics enzyme product line in development. Clairmont previously served as chief operating officer of BRIDGenomics. She was with Qiagen for eight years, most recently in the global advanced molecular pathology team as director of sales in America, and was also technical marketing representative and account manager at BioArray Solutions (now part of Immucor).

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.